Myeodysplastic Syndrome
1 clinical trials · Condition
◉ Watch Myeodysplastic Syndrome
| Record | Firm | Date |
|---|---|---|
| Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. (NCT04771572) | Newave Pharmaceutical Inc | 2022-05-08 |
Track Myeodysplastic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.